제품번호 | 종 | 제품 설명 | 구조 | 순도 | 특징 |
---|---|---|---|---|---|
RO2-H82E3 | Human | Biotinylated Human ROR2 / NTRKR2 Protein, His,Avitag™ | ![]() |
![]() ![]() |
|
RO2-M5253 | Mouse | Mouse ROR2 / NTRKR2 Protein, Fc Tag | ![]() |
![]() ![]() |
|
RO2-H52E5 | Human | Human ROR2 / NTRKR2 Protein, His Tag | ![]() |
![]() ![]() |
|
RO2-H5251 | Human | Human ROR2 / NTRKR2 Protein, Fc Tag | ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Ozuriftamab Vedotin | CAB-ROR2-ADC; CAB-ADC; CAB-ROR2; BA-3021; HTBA-3021 | Phase 2 Clinical | Bioatla | Solid tumours; Ovarian Neoplasms; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
CCT301-59 | CCT301-59 | Phase 2 Clinical | Bioatla, F1 Oncology | Solid tumours; Carcinoma, Renal Cell; Stomach Neoplasms; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Sarcoma | Details |
This web search service is supported by Google Inc.